Q Therapeutics
About Q Therapeutics
Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 13 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 24218047 USD
- Last Funding: 5200000 USD (Venture - Series Unknown)
- Funding Status:
Technology Stack
Q Therapeutics actively uses 13 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Therapeutics
Headquarters: Salt Lake City, Utah, United States